Your browser doesn't support javascript.
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.
Martin-Blondel, Guillaume; Lescure, François-Xavier; Assoumou, Lambert; Charpentier, Charlotte; Chapplain, Jean-Marc; Perpoint, Thomas; Grouteau, Gaspard; Cordel, Hugues; Pialoux, Gilles; Pacanowski, Jérome; Thy, Michael; Bauvois, Adeline; Laureillard, Didier; Hamrouni, Fadia; Algarte-Genin, Michèle; Poissy, Julien; Descamps, Diane; Costagliola, Dominique.
  • Martin-Blondel G; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. martin-blondel.g@chu-toulouse.fr.
  • Lescure FX; Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse, France. martin-blondel.g@chu-toulouse.fr.
  • Assoumou L; Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.
  • Charpentier C; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.
  • Chapplain JM; Service de Virologie, Université de Paris, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, 75018, Paris, France.
  • Perpoint T; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Rennes, Rennes, France.
  • Grouteau G; Service des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France.
  • Cordel H; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
  • Pialoux G; Service des Maladies Infectieuses et Tropicales, Hôpital Avicenne, AP-HP, Bobigny, France.
  • Pacanowski J; Service des Maladies Infectieuses et Tropicales, Hôpital Tenon, APHP, Paris, France.
  • Thy M; Service des Maladies Infectieuses et Tropicales, Hôpital Saint-Antoine, APHP, Paris, France.
  • Bauvois A; Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.
  • Laureillard D; Service de Médecine Interne, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France.
  • Hamrouni F; Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.
  • Algarte-Genin M; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.
  • Poissy J; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.
  • Descamps D; University of Lille, Inserm U1285, CHU Lille, Pôle de Médecine Intensive Réanimation, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000, Lille, France.
  • Costagliola D; Service de Virologie, Université de Paris, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, 75018, Paris, France.
BMC Infect Dis ; 22(1): 540, 2022 Jun 13.
Article in English | MEDLINE | ID: covidwho-1951099
ABSTRACT

BACKGROUND:

The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France.

METHODS:

We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patients infected by historical lineages. Participants were matched on age (± 2.5 years), sex and region of hospitalization. The primary endpoint was the proportion of hospitalized participants with severe COVID-19, defined as a WHO-scale > 5 or by the need of a non-rebreather mask, occurring up to day 29 after admission. We used a logistic regression model stratified on each matched pair and accounting for factors known to be associated with the severity of the disease.

RESULTS:

We included 650 pairs of patients hospitalized between Jan 1, 2021, and Feb 28, 2021, in 47 hospitals. Median age was 70 years and 61.3% of participants were male. The proportion of participants with comorbidities was high in both groups (85.0% vs 90%, p = 0.004). Infection by VOC Alpha was associated with a higher odds of severe COVID-19 (41.7% vs 38.5%-aOR = 1.33 95% CI [1.03-1.72]).

CONCLUSION:

Infection by the VOC Alpha was associated with a higher odds of severe COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Aged / Female / Humans / Male Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07508-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Variants Limits: Aged / Female / Humans / Male Language: English Journal: BMC Infect Dis Journal subject: Communicable Diseases Year: 2022 Document Type: Article Affiliation country: S12879-022-07508-x